Monoclonal antibodies have also been developed to another type 2 cytokine, thymic stromal lymphopoietin (TSLP), which was implicated in asthma using genome-wide association studies (GWAS), and these TSLP monoclonal antibodies were recently tested in a clinical trial [6]. The gene discussed is TSLP; the disease is asthma.